Cladribine, cytarabine, and filgrastim based regimen in relapsed or refractory acute myeloid leukemia: A systematic review and meta-analysis

BACKGROUND: To ascertain the efficacy and safety of cladribine, cytarabine, and filgrastim-based regimen in relapsed or refractory (R/R) AML patients. METHODS: Clinical studies were searched in PubMed, Cochrane Library, Embase data. We selected available factors including complete remission (CR), ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Susu, Tao, Qianshan, Wang, Jia, Zhang, Qing, Dong, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627662/
https://www.ncbi.nlm.nih.gov/pubmed/37933074
http://dx.doi.org/10.1097/MD.0000000000034949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627662/
https://www.ncbi.nlm.nih.gov/pubmed/37933074
http://dx.doi.org/10.1097/MD.0000000000034949

Ejemplares similares